PHAXIAM Therapeutics

Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 51-100 Employees

Company overview

Headquarters	60 avenue Rockefeller, Bâtiment Bioserra, LYON, Rhône-Alpes 69008, FR
Phone number	+33478744438
Website	phaxiam.com
Keywords	Biotechnology, Innovation, Viruses, Phage, Pseudomonas Aeruginosa, Staphylococcus Aureus, Bacterial Infection, Escherichia Coli, Phxm
Founded	2004
Employees	51-100
Socials

Key Contacts at PHAXIAM Therapeutics

Thibaut Du Fayet

Chief Executive Officer Ceo

Emily Bennett

Director, Biotechnology & Oncology | Strategic Partnerships | Cell Therapy

PHAXIAM Therapeutics Email Formats

PHAXIAM Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@phaxiam.com), used 45.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@phaxiam.com	45.5%
{first initial}.{last name}	j.doe@phaxiam.com	36.4%
{first initial}.{second initial}{last name}	j.odoe@phaxiam.com	18.2%

About PHAXIAM Therapeutics

PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.

PHAXIAM Therapeutics revenue & valuation

Annual revenue	$5,389,965
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,300,000
Total funding	$8,400,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

PHAXIAM Therapeutics has 27 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore PHAXIAM Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-07-12	14	$8,400,000

Funding Insights

$8,400,000

Total funding amount

$8,400,000

Most recent funding amount

Number of funding rounds

PHAXIAM Therapeutics Tech Stack

Discover the technologies and tools that power PHAXIAM Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

MonsterInsights

Analytics

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Splide

JavaScript libraries

Yoast SEO

SEO

Frequently asked questions

PHAXIAM Therapeutics is located in Lyon, Auvergne-Rhône-Alpes, FR.

You can reach PHAXIAM Therapeutics at +33478744438.

PHAXIAM Therapeutics was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

PHAXIAM Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

PHAXIAM Therapeutics has raised a total of $8,400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at PHAXIAM Therapeutics

Thibaut Du Fayet

Chief Executive Officer Ceo

Emily Bennett

Director, Biotechnology & Oncology | Strategic Partnerships | Cell Therapy

4.8

40,000 users